R
Research Management, Inc. | Austin Kidney Associates
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Bardoxolone Methyl
Ferric Citrate
KRX-0502
Iron
Semaglutide
Clazakizumab
PF-00489791
Parent organization
This site is a part of Research Management, Inc.
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
2 of 13 total trials
This is a 2-part (phase 2b/3) prospective, interventional, multicenter, randomized, double-blind, placebo-controlled study. Part 1 (phase 2b) is a do...
Enrolling
Atherosclerotic Cardiovascular Disease
Atherosclerotic Cardiovascular Disease in Patients With ESKD
Drug: Placebo
Drug: CSL300
To Evaluate the Efficacy and Safety of Sibeprenlimab Administered Subcutaneously in Subjects with Primary Immunoglobulin A Nephropathy
Active, not recruiting
Immunoglobulin A Nephropathy
Drug: Sibeprenlimab 400 mg
Drug: Placebo
Trial sponsors
K
Clinical trials
Research sites
Resources
Legal
© Copyright 2026 Veeva Systems